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Abstract
Since the discovery of Fibroblast Growth Factors much focus has been placed on elucidating the
roles for each vertebrate FGF ligand, receptor, and regulating molecules in the context of
vertebrate development, human disorders and cancer. Studies in human, mouse, Xenopus, chick,
and zebrafish have gone a long way to help us understand [AS1]which FGFs are involved in
which processes. However, in recent years, as more genomes are sequenced, more information is
becoming available from many non-vertebrate models and a more complete picture of the FGF
superfamily as a whole is emerging. In some cases less redundancy in the FGF signaling system in
invertebrate models may allow for more mechanistic insights. Studies in cnidaria have highlighted
how ancient FGF signaling is, and helped provide insight into the evolution of the FGF gene
family. Work in C. elegans has shown that different splice forms can be used for functional
specificity in invertebrate FGF signaling. Comparing FGFs from Ciona to those in vertebrates and
FGFs from Tribolium to Drosophila reveals some important clues as to the process of gene loss,
duplication and subfunctionalization of FGFs throughout evolution. Finally, comparing all
members of the FGF ligand superfamily reveals variability in many properties, which may point to
a feature of FGFs as being highly adaptable with regards to protein structure and mechanism.
Further studies on FGF signaling outside of vertebrates is likely to complement work in
vertebrates by contributing many insights to the FGF field as a whole and providing unexpected
information that could be used for medical applications.
Introduction
Cell signaling by Fibroblast Growth Factors (FGF) is essential to the development and
maintenance of animals. From their discovery in the early 1970s to today, researchers
continue to detail the contributions of FGF signaling to developmental and adult metabolic
processes. It has become clear that FGF signaling is not limited to a few uses, but has many
functions both in developing embryos and the adult. As more genomes are sequenced and
more FGF superfamily members are described, the amount of structural and functional
variety within the family is becoming apparent and FGF signaling appears to be highly
adaptable, helping to make possible the great variety of life forms. In this review we will
first highlight the history of FGF research, the structure of the FGF signaling complex, the
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downstream pathways employed and major functional findings from vertebrate FGF
research. Then, we will discuss findings from non-vertebrate models in the context of
emerging themes in FGF superfamily research.
Historical perspective
A prelude to the discovery of FGFs was the finding in 1939 that bovine brain extracts could
cause proliferation of fibroblast cell lines in vitro (Hoffman, 1940; Mohammadi et al., 2005;
Trowell OA, 1939). Biochemical characterization of this mitogenic activity did not begin for
another 34 years, when a factor in pituitary extracts was found to stimulate growth of 3T3
mouse fibroblast cells and was characterized as being thermolabile, sensitive to proteases
and enhanced by hydrocortisone (Armelin, 1973). Gospodarowicz (1974) purified the
mitogenic factor from pituitary extracts and found it was also present at higher
concentrations in brain extracts. He termed this molecule Fibroblast Growth Factor and
showed that with hydrocortisone FGF could stimulate DNA synthesis as effectively as crude
serum (Gospodarowicz, 1974). Another important finding from these early studies was the
incredible potency of FGF: the minimal effective dose was only 0.1 ng ml−1. It was also
found that FGF could induce proliferation of diploid human foreskin fibroblasts and mouse
fibroblast cells, showing that FGF lacks species specificity (Gospodarowicz and Moran,
1975). FGF activity was found to be due to a 15 kD molecule and was called basic FGF
(bFGF) because of its high isoelectric point (pI) (Gospodarowicz, 1975; Gospodarowicz,
1978). Another molecule with FGF activity was also isolated from brain extracts and was
called acidic FGF (aFGF) because of its lower pI (Maciag et al., 1979).
A number of other mitogenic proteins were subsequently found to be chemically identical to
either aFGF or bFGF (Burgess and Maciag, 1989; Burgess et al., 1986; Lemmon et al.,
1982; Libermann et al., 1987; Mohammadi et al., 2005). More members of the FGF family
were found using several approaches and a numbering-scheme was established in which
aFGF and bFGF were renamed as FGF1 and FGF2, respectively. FGF3 (INT-2) (Dickson et
al., 1984), FGF4 (K-FGF/HST) (Delli Bovi and Basilico, 1987; Sakamoto et al., 1986), and
FGF5 (Zhan et al., 1988) were all discovered as oncogenes. FGF6 was identified based on
the similarity of its sequence to FGF4 (Marics et al., 1989). FGF7 was discovered with
classical protein purification from fibroblasts and this study showed for the first time that
FGFs are necessary for tissue homeostasis by enabling communication between
mesenchymal and epithelial tissues (Rubin et al., 1989). FGF8 was isolated as an androgen-
induced growth factor (Tanaka et al., 1992). FGF9 was found because of its ability to
stimulate the growth of glia cells (Miyamoto et al., 1993).
Between 1996 and 2003, other FGFs were found through a combination of bioinformatic
tools and homology-based PCR: FGF10 (Lu et al., 1999), FGF16 (Miyake et al., 1998),
FGF17 (Xu et al., 1999), FGF18 (Ohbayashi et al., 1998), FGF19 (Nishimura et al., 1999),
FGF20 (Kirikoshi et al., 2000), FGF22 (Nakatake et al., 2001), FGF23 (Yamashita et al.,
2000), FGF24 (Draper et al., 2003). FGF11-FGF14 make up a subfamily of Fibroblast
Homologous Factors (FHFs) that are not secreted and do not bind to FGF receptors (FGFR)
1–4 (Coulier et al., 1997; Smallwood et al., 1996). FHFs can also bind to heparin with high
affinity like the canonical FGFs, yet despite striking structural similarity, FHFs have
Tulin and Stathopoulos Page 2
Birth Defects Res C Embryo Today. Author manuscript; available in PMC 2014 August 04.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
diverged toward interaction with a separate set of target proteins and do not share functional
homology with FGFs (Olsen et al., 2003).
Today, the FGF family represents one of the largest signaling families in vertebrates, with
24 known ligands in total, although not every member is present in every vertebrate species.
The first FGF receptor (FGFR) was identified in the mid-1980’s (Lee et al., 1989; Olwin and
Hauschka, 1986), and since then 4 FGFRs have been found in vertebrates (Coumoul and
Deng, 2003).
Structure of FGF ligands, receptors, and signaling complex
FGF ligands share a homologous core domain consisting of 120–130 amino acids ordered
into 12 antiparallel β-strands (β1-β12) that are arranged into three sets of four-stranded β-
sheets that fold to form a β-trefoil structure (Mohammadi et al., 2005). Additionally, they
have variable length N- and C-terminal tails, which largely account for the specific biology
of different FGF family members. Most FGFs have traditional signal peptides and are
secreted as soluble signaling molecules. Vertebrate FGFs are also known to bind to heparan
sulfate glycosaminoglycans (HSGAG) through the HSGAG binding site (HBS), located in
the FGF core within the β1-β2 loop and the region between β10-β12. The elements of the
HBS form a contiguous, positively charged surface.
FGF ligands bind to the FGFR family of tyrosine kinase receptors in an heparan sulfate
proteoglycan(HSPG)-dependent manner. In vertebrates there are 4 FGFRs (FGFR1-FGFR4)
which bind to the 24 ligands with varying degrees of promiscuity. The structure of the
FGFR consists of three extracellular immunoglobulin domains (D1-D3), a transmembrane
domain, and an intracellular tyrosine kinase domain. A unique feature of FGFR is the
presence of an acidic, serine-rich sequence in the linker between D1 and D2, which is
known as the acid box. The FGF ligands bind to the D2-D3 region of the FGFR ectodomain.
The D1 and acid box are thought to play a role in receptor autoinhibition (Mohammadi et
al., 2005).
A functional FGF-FGFR signaling unit consists of two 1:1:1 FGF-FGFR-HSGAG
complexes that are bound together into a dimer. The ligand of each complex binds to both
receptors to allow interaction with each other through a region in the D2 domain. The
HSGAG incorporates into the dimer through a “basic canyon” and contributes to
dimerization by binding both the ligands and the receptors (Beenken and Mohammadi,
2009). Additionally, HSGAGs stabilize FGFs against degradation, act as a storage reservoir,
and can affect the radius of ligand diffusion (Häcker et al., 2005). Dimerization of FGFR
allows the cytoplasmic kinase domains to become activated (Mohammadi et al., 1996).
Signaling transduction pathways utilized
Several reviews have been written detailing the research on downstream signaling pathways
used by FGF signaling (Böttcher and Niehrs, 2005; Eswarakumar et al., 2005; Thisse and
Thisse, 2005), and therefore we will only review briefly here this aspect of FGF signaling.
FGFR-stimulation leads to tyrosine phosphorylation of Shp2 resulting in complex formation
of Grb2 and its associated nucleotide exchange factor son-of-sevenless (Sos) and Grb2/Sos
activate the Ras GTPase, which then activates the mitogen-activated protein kinase (MAPK)
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pathway. The final protein in the MAPK pathway is extracellular signal-regulated kinase
(ERK) and it enters the nucleus to activate transcription factors (c-myc, AP1 and Ets-family
members) that will affect FGF target genes.
The MAPK pathway is not the only pathway used by FGF signaling. Mutational analysis of
tyrosine766 has shown that the phosphorylation of this tyrosine residue is essential for
complex formation with and tyrosine phosphorylation of phospholipase C gamma (PLCγ)
(Eswarakumar et al., 2005). PLCγ activation results in the hydrolysis of
phosphatidylinositol-4,5-diphosphate (PIP2) to inositol-1,4,5-triphosphate (IP3) and the
generation of two second messengers: IP3 and diacylglycerol (DAG). Recruitment to the
membrane of PLCγ is mediated by binding of the Pleckstrin homology domain of PLCγ to
IP3 molecules. IP3 causes a release of calcium within the cell, which stimulates GEFs that
activate the Rap1 GTPase. Rap1 can assist in the maturation of intercellular junctions and
mediate adhesion through the recruitment of cadherins and integrins to the plasma
membrane. Signaling through the FGFR can thus result in multiple responses: cellular
differentiation through Ras GTPase and cell adhesion/migration through PLCγ/Rap1
(Raaijmakers and Bos, 2009).
The PI3 Kinase/Akt pathway can be activated in three ways: (1) Gab can bind to FRS2 via
Grb2, (2) the PI3 subunit p85 can bind to a phosphorylated tyrosine residue of the FGFR,
and (3) activated Ras can induce membrane localization and activation of the p110 catalytic
subunit of P13 kinase (Böttcher and Niehrs, 2005).
The different downstream signal transduction pathways used by FGF signaling can lead to
specific cellular response in a cell-type dependent manner (Dailey et al., 2005). For instance,
the ERK kinases are generally thought to be responsible for the mitogenic response of cells
to FGF, while alternate MAPKs, p38 and JNK MAP kinase are usually associated with
inflammatory or stress-response.
Functional information from vertebrate studies
The cumulative data [DM8]from studies on FGF signaling in vertebrate models is difficult
to summarize in brief. Reviews on FGF functions in vertebrates have been written at regular
intervals and include information on FGFs involved in developmental processes, adult
maintenance, disorders and cancer (Beenken and Mohammadi, 2009; Ornitz and Itoh, 2001;
Thisse and Thisse, 2005). Among other functions, FGFs are key regulators of development,
including: mesoderm induction, gastrulation, limb development, midbrain-hindbrain
patterning, and bone formation. In the mouse, FGF4 and FGF8 are required for proper
migration of epiblast cells through the primitive streak. In the absence of both FGF4 and
FGF8, epiblast cells move into the streak and undergo an epithelial-to-mesenchymal
transition, but then most cells fail to move away from the streak (Sun et al., 1999; Thisse
and Thisse, 2005). Currently it is thought FGF4 is thought to act as an attractant and FGF8
as a repellent to cells in the streak. [DM9]FGF induction of mesoderm has also been studied
in Xenopus laevis, where FGF2 was first shown to have mesoderm inducing activity
equivalent to the ventrovegetal signal (Slack et al., 1987). More recently, the specific roles
of different spliceforms of FGF8, FGF8a and FGF8b, have been found to have different
activities in the early specification of mesodermal and neural tissue in the frog. FGF8b is a
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potent mesoderm inducer in both explants and whole embryos while FGF8a has little effect
on the development of mesoderm (Fletcher et al., 2006).
Limb Development—FGFs have been found to play key roles in the process of limb
development. Formation of limb buds and their successful outgrowth is dependent upon
FGF signaling and a FGF positive-feedback signaling loop between the limb mesenchyme
(progress zone) and the overlying ectoderm, termed the apical ectodermal ridge (AER).
FGF4, FGF8, FGF9 and FGF17 are all expressed in the AER. Combinatorial FGF mutant
studies resulted in the loss of intermediate skeletal structures while the most distal and the
most proximal structures remained intact, leading to a the ‘two-signal model,’ which
describes limb mesenchyme initially being influenced by one signal (likely Retinoic Acid)
that influence proximal cell fates and subsequently experience FGF signals from the AER
establishing the distal domain. The intermediate domain would then form as a result of
interactions at the domain boundary. Sonic hedgehog (Shh) is expressed in a posterior
domain of the limb bid called the zone of polarizing activity (ZPA) and a positive feedback
loop is established between Shh in the ZPA and FGFs in the AER. Shh is required for the
induction and maintenance of Fgf4, 9, 17 and the maintenance of Fgf8, and, reciprocally,
FGF signaling from the AER is required to maintain Shh expression (Duboc and Logan,
2009)
Brain Patterning—Patterning of the midbrain-hindbrain (MHB) anlage depends on an
organizer activity located at the MHB junction, also known as the Isthmus. In vertebrates,
FGF8 is expressed in the MHB and is a key component of its organizing activity (Crossley
et al., 1996). Loss of midbrain and cerebellar tissue results in a mouse with a severe
hypomorphic allele of Fgf8 (Meyers et al., 1998). FGF17 and FGF18 are also expressed in
the MHB and the loss of FGF17 in mouse results in the truncation of posterior midbrain and
reduced proliferation of the anterior cerebellum (Maruoka et al., 1998). FGF8 is
differentially spliced to generate FGF8a and FGF8b isoforms, which are both expressed at
the isthmus/MHB (Sato et al., 2001). In the chick, ectopic FGF8a causes expansion of the
midbrain whereas misexpression of FGF8b transforms the midbrain into a cerebellum (Sato
et al., 2001). Similarly, in the mouse, ectopic FGF8a results in expansion of the midbrain
and ectopic expression of Engrailed2, whereas ectopic FGF8b leads to exencephaly and a
rapid transformation of the midbrain and diencephalon into an anterior rhombomere1[AS11]
fate (Liu et al., 1999). FGF8b also maintains two negative feedback loops by inducing the
expression of the negative feedback FGF inhibitors Sprouty1 and Sprouty2 and repressing
FGFR2 and FGFR3 (Liu et al., 2003). In Zebrafish, FGF8 is also present at the MHB and
acts as a morphogen to pattern the midbrain. Acerebellar mutants, in which the FGF8 gene
contains a premature stop codon, lack a functional MHB and also lacks a cerebellum
(Reifers et al., 1998).
Bone Formation—FGF signaling is capable of regulating genes at all steps of
osteogenesis. A point mutation in the transmembrane domain of FGFR3 was found to be the
etiology of Acondroplasia, the most common genetic form of human dwarfism (Rousseau et
al., 1994; Shiang et al., 1994). Missense mutations have since been found in more than 15
human bone disorders, from skeletal dysplasias to short stature. FGF2, FGF9, and FGF18
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are all found in osteoblasts. Overexpression of FGF2 in mouse causes abnormal bone
formation and loss-of-function of FGF2 leads to inhibition of bone formation (Coffin et al.,
1995; Montero et al., 2000). FGF signaling seems to positively regulate cell proliferation
and differentiation in osteogenesis. Additionally, FGFs can control apoptosis in osteoblasts
when high levels of FGF signaling can reduce apoptosis in immature osteoblasts and
increase the total osteoblast population.
Other developmental functions for FGFs in vertebrates have been described as well in many
tissues: the nervous system, epidermis, lungs, mammary glands, somite boundaries, ear,
kidney, liver, and pancreas (Coleman-Krnacik and Rosen, 1994; Delaune et al., 2005;
Kobberup et al., 2010; Sawada et al., 2001; Thisse and Thisse, 2005; Wilkie, 2005).
Insights from non-vertebrate models
An Introduction to non-vertebrate FGFs and FGFRs
FGF signalling has now been described in a number of model systems outside of vertebrates
including the echinoderm sea urchin Strongylcentrotus purpuratus, the urochordate
ascidians Ciona intestinalis and Ciona savigny, the ecdysozoans Caenorhabditis elegans,
Drosophila melanogastor, and Tribolium castaneum, and the anthozoan cnidarian,
Nematostella vectensis. The relationship of these groups to vetebrates is summarized in
Figure 1.
This list will surely expand in the near future, but it is worth surveying the current described
members of the FGF family outside of vertebrates (Table 1). In the sea urchin, they have
identified one ligand, FGFA, and two receptors, FGFR1 and FGFR2 (Lapraz et al., 2006;
McCoon et al., 1996; McCoon et al., 1998; Röttinger et al., 2008). The ligand was called
FGFA because the predicted protein showed similarities to both the FGF8 and FGF9
subfamilies and phylogenetic analysis gave ambiguous results. Ciona has 6 FGF ligands and
1 receptor: Ci-FGF8/17/18, Ci-FGF11/12/13/14, Ci-3/7/10/22, Ci-FGF4/5/6, Ci-
FGF9/16/20, Ci-FGFL (FGF with large molecular mass), and Ci-FGFR (Satou et al., 2002;
Shi et al., 2009). In Drosophila, there are three FGF ligands: Branchless (Bnl), Thisbe (Ths),
and Pyramus (Pyr). Ths and Pyr are most related to the FGF8 subfamily. Additionally, there
are two FGFRs: Bnl uses the Breathless FGFR (Btl), and Ths and Pyr signal through the
Heartless receptor (Htl). Tribolium has 4 FGF ligands and a single FGFR: Tc-FGF1a, Tc-
FGF1b, Tc-FGF8, Tc-Branchless (Tc-Bnl), and Tc-FGFR (Beermann and Schröder, 2008).
In C. elegans, there are two FGF ligands, egl-17 and LET-756, and one FGFR, egl-15.
Egl-17 is most similar to the FGF8 subfamily and LET-756 to the FGF9 subfamily. In the
anthoszoan cnidarian Nematostella vectensis, there are 4 ligands and 2 receptors: NvFGF8A,
NvFGF8B, NvFGF1A, NvFGFa2, NvFGFRa, and NvFGFRb (Matus et al., 2007; Rentzsch et
al., 2008). A probable FGFR, kringelchen, has been identified in the hydrozoan cnidarian
Hydra (Sudhop et al., 2004). Two FGFRs, Dj-FGFR1 and Dj-FGFR2 have been found in the
platyhelminthes planarian Dugesua japonica, rounding out representatives from all the
major metazoan phyla (Ogawa et al., 2002).
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The role of FGFs in development is an ancient one
FGF signaling is an ancient cell-to-cell communication system as evidenced by its presence
in the cnidaria, which split off from its sister group bilateria an estimated 600 million years
ago (Rentzsch 2008). Nematostella vectensis, a sea anemone, is considered to be a
representative of basal cnidarians and to have retained much of the genetic complexity
contained in the cnidarian-bilaterian ancestor (Bridge et al., 1995; Bridge et al., 1992;
Chourrout et al., 2006; Collins et al., 2006; Medina et al., 2001; Putnam et al., 2007; Ryan et
al., 2006; Technau et al., 2005). The two FGFRs identified in Nematostella, NvFGFRa and
NvFGFRb are thought to have arisen from a lineage-specific duplication, and therefore, it is
thought likely that there was only 1 FGFR in the cnidarian-bilaterian ancestor (Rentzsch et
al., 2008). As many as 15 putative transcripts sharing homology to FGF domains were found
via bioinformatic analyses in the Nematostella genome, but so far only four have been
described: NvFGF1A, NvFGFa2, NvFGF8A, NvFGF8B (Matus et al., 2007; Rentzsch et al.,
2008).
In bilaterians, FGF ligands and FGF receptors are often expressed in separate germ layers or
tissues and signal across epithelial-mesenchymal boundaries. Yet, in diploblastic cnidarians
there is no mesoderm for FGFs to signal to/from, and so the ligands and receptors are
expressed in the same domain (NvFGF1A, NvFGFa2, NvFGFRa), or in abutting ectoderm/
endoderm tissues of the aboral pole (NvFGF8A, NvFGFRb).
Morpholino knockdown of NvFGF1A and NvFGFRa showed that they are required for
formation of the apical organ (Rentzsch et al., 2008). Apical organs with a ciliated tuft are
also present in both protostomes and deuterostomes: in the larvae of sea urchins,
hemichordates, and the polychaete Platynereis, although the evolutionary relationship of
cnidarian, protostomian and deuterostomian apical organs has not yet been determined.
Intriguingly, FGFs or FGFRs are expressed in the region of apical organ formation in sea
urchin, hemichordates and polychaetes, leading to the possibility of an ancient function in
apical organ formation.
A tyrosine kinase receptor with similarity to FGFR, kringelchen, has also been identified in
the hydrozoan cnidarian Hydra, where it was shown to be essential for boundary formation
and tissue constriction as a prerequisite for proper bud detachment which is essential for
reproduction (Sudhop et al., 2004). It has yet to be shown that this receptor can actually bind
FGFs, which have not been described yet for Hydra.
Importance of tight regulation in FGF signaling
Evidence from many systems has pointed to the importance for tight regulation of FGF
signaling activity, and the loss of such regulation often leads to developmental disorders and
disease. A negative regulator of FGF signaling, Sprouty, was originally identified in
Drosophila for its action during tracheal development (Hacohen et al., 1998). Sprouty is
thought to act in a negative-feedback regulatory loop during FGF and EGF signaling (Casci
et al., 1999; Kramer et al., 1999; Sivak et al., 2005). There are four mammalian Sprouty
proteins and three related Spreds (Sprouty-related EVHI domain proteins). Sproutys have
been found in synexpression groups with FGFs and FGFRs in other nonvertebrate systems.
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Nematostella Sprouty, Nv-Sprouty, is expressed in the same domain as NvFGF8A,
NvFGF8B and NvFGFRa in the apical pole (Matus et al., 2007). The expression of the sea
urchin sprouty largely follows that of fgfA from the late mesenchyme blastula/early gastrula
to pluteus stages in bilateral regions of the ectoderm, in the PMC clusters, and at the tip of
the growing arms of the larva (Röttinger et al., 2008). Two other probable FGF target genes,
pea3 (Polyoma enchancer activator 3), an Ets domain transcription factor, and paired
transcription factor pax2/5/8, were also expressed along with fgfA and sprouty (Röttinger et
al., 2008). Sprouty proteins can have a therapeutic effect on some mouse models of disease
by enhancing angiogenesis and neovascularization (formation of new blood vessels from
preexisting ones) (Taniguchi et al., 2009). Many of the studies in vertebrates relied on
double mouse knockouts for combinations of different Sproutys and Spreds. Studies on
Sprouty proteins in nonvertebrate models may aid in the further characterization of the
mechanism of regulation without the concern of redundancy.
Regulation has also been found to come from certain FGF ligands themselves when co-
expressed in the same domain as the functioning ligand. In Nematostella, NvFGFa2
negatively regulates FGF signaling at the apical pole, as a morpholino against NvFGFa2
causes the expansion of the apical tuft region along with the expansion of expression of
NvFGF1A and NvFGFRa (Rentzsch et al., 2008). This may be related to the function of
FGFRL1 molecules (see below, Survey Approach to FGFRL1).
Multiple isoforms of FGFs and FGFRs are generated by splicing
The possible ligand-receptor combinations in vertebrates are numerous and increased by
different receptor splice forms. Multiple isoforms are thought to contribute to ligand-
receptor specificity and functional specificity. Several examples are also present outside of
vertebrates of alternate splice forms of FGFs and FGFRs contributing to functional
specificity. C. elegans has two ligands LET-756 and EGL-17 and a single receptor, EGL-15
(Birnbaum et al., 2005). EGL-15 is located on the X chromosome and encodes two
isoforms, EGL-15(5A) and EGL-15(5B), which result from alternative splicing of exon 5. It
has been shown genetically that the different isoforms mediate signaling through two
different modules, each using a specific ligand. Egl-15(5A) interacts with egl-17 to mediate
sex myoblast chemoattraction and egl-15(5B) carries out an essential function required for
viability, presumably through signaling by let-756 (Goodman et al., 2003). Perhaps multiple
isoforms are especially important when a single receptor is required to mediate separate
functions from two different ligands.
Ciona FGF8/17/18 has two alternative forms of transcripts, that differ in their N-terminal
regions (Satou et al., 2002). However, one form is missing the N-terminal region of the FGF
domain and whether it is used for signaling and/or regulation is not known.
FGFs have been lost, duplicated and undergo subfunctionalization
Characterizing the complement of FGF ligands in non-vertebrate taxa has provided insight
into the evolution of the FGF superfamily across the Metazoa (Popovici et al., 2005). It is
clear that in some lineages FGF/FGFR genes have been lost, where in other cases they have
been duplicated once or multiple times. Comparisons of FGFs in Ciona to vertebrates
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reveals that at least two rounds of duplications of most FGF ligands and the FGFR were
necessary to account for the multiple subfamily members in vertebrate genomes. It is
generally thought that this is consistent with the “2R hypothesis,” which maintains that two
rounds of whole genome duplication occurred at the base of vertebrate ancestry (Holland et
al., 1994; Ohno, 1970).
It has been proposed that the 7 FGF subfamilies present in vertebrates (A–G) plus 1
additional subfamily lost in deuterostomes (H) represent what was once 8 proto-FGF genes
in the protostome-deuterostome ancestor (Popovici et al., 2005). Ciona has six FGFs, 2 of
which were confidently assigned to FGF subfamilies D and F (Ci-FGF8/17/18 and
Ci-11/12/13/14) (Satou et al., 2002). Probable placement in subfamilies B, C, and E was
made for an additional 3 FGFs in Ciona (Ci-FGF3/7/10/22, Ci-4/5/6, and Ci-9/16/20). The
last FGF in Ciona, Ci-FGFL is characterized by its large predicted molecular mass and
could not be assigned to any particular FGF subfamily with confidence. Possible
assignments include grouping with other invertebrate FGFs like Branchless in subfamily H,
or as a member of subfamily A, B or G (FGF1/FGF2, FGF3/7/10/22 and FGF15/FGF19/
FGF21/FGF23, respectively) but its sequence has diverged beyond the similarity required
for phylogenetic analysis (Popovici et al., 2005; Satou et al., 2002).
Over time duplicated genes can undergo subfunctionalization to take over different
responsibilities. In some cases the combined functions of the two genes equal the function of
the original gene, and sometimes the presence of a “backup” gene allows the duplicate or
original gene to explore new functional space.
Ciona vs vertebrate FGFs—Many functional studies have been performed on FGFs in
Ciona and comparisons to studies in vertebrates yield some important similarities (Beh et
al., 2007; Bertrand et al., 2003; Davidson et al., 2006; Imai et al., 2002; Kourakis and Smith,
2007; Shi et al., 2009; Yasuo and Hudson, 2007). Ci-9/16/20 has been shown to be involved
in the induction of notochord, induction of mesenchyme, and heart specification (Davidson
et al., 2006; Imai et al., 2002). Ci-9/16/20 is expressed adjacent to the heart-producing B7.5
lineage and morpholino knockdown of Ci-9/16/20 results in the disruption of heart lineage
markers Mesp, NoTrlc/Hand-like, Tolloid, FoxF (Davidson et al., 2006; Imai et al., 2006).
FGF9 and FGF16 are also known to be involved in heart development in the mouse.
Knockout mice for both FGF9 and FGF16 (but not a double mutant) have been generated
and have a similar phenotype of reduced number of cardiomyoctes and smaller embryonic
heart (Hotta et al., 2008; Lavine et al., 2005). FGF9 and FGF16 are thought to act
synergistically to promote the proliferation of embryonic cardiomyocytes. Epicardial and
endocardial FGF9/FGF16 signaling through FGFR1/FGFR2 is essential for myocardial
proliferation and differentiation (Lavine et al., 2005). In this case it seems that the vertebrate
paralogs FGF9 and FGF16 have retained a function in heart development (although possibly
not homologous) compared to FGF9/16/20 in Ciona. FGF9 and FGF16 seem to be function
redundantly at this stage of development with no subfunctionalization apparent.
Ciona FGF3/7/10/22 is expressed in the ventral midline of the neural tube and is important
for convergent extension movement in the developing embryo (Shi 2009). In the Xenopus
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neurula FGF signaling has been implicated in axial elongation as well and possibly a similar
mechanism is at play, however the details are still unclear (Sivak et al., 2005).
Ciona FGF8/17/18 is expressed in the nervous system of ascidian embryos and is thought to
play a similar role to the patterning of the brain territories that FGF8/FGF17/FGF18 play in
vertebrates (see midbrain-hindbrain section of introduction). Ci-FGF8/17/18 is expressed in
the developing central nervous system (CNS) in a region analogous to the MHB of
vertebrate embryos and has led to the hypothesis that a precursor to the organizing activity
of FGF8 in the MHB in vertebrates was this region of Ci-FGF8/17/18 expression bewteen
Otx and Hox genes in Ciona (Ikuta and Saiga, 2007; Imai et al., 2002). Interestingly, 3 other
Ciona FGFs are also expressed in the developing CNS: Ci-9/16/20, Ci-3/7/10/22, and Ci-
FGFL (Imai et al., 2002). Morpholino knockout analysis of Ci-FGF8/17/18 has revealed that
this ancestor of FGF8/FGF17/FGF18 plays a central role in generating regional patterns of
gene expression as morphants have altered expression of Otx, en, FoxB, Pax2/5/8, and Hox
1 (Imai et al., 2009). In vertebrates, FGF17 and FGF18 are also expressed in the mid/
hindbrain in a broader domain than FGF8 that includes posterior midbrain (Maruoka et al.,
1998). Loss of one copy of fgf8 in an fgf17 mutant background results in an exaggerated
cerebellum phenotype (Xu et al., 2000). Ectopic FGF8 studies in the chick showed that only
ectopic FGF8 leads to the expression of Engrailed-2, an early marker of mes/
rhombencephalic development, Wnt1, and Fgf8 (Crossley et al., 1996). Ectopic FGF8 can
also lead to expression of Engrailed-1, Pax2 and Pax5, and suppression of Otx2 expression
(Liu et al., 1999; Martinez et al., 1999; Shamim et al., 1999; Sheikh and Mason, 1996). It
therefore appears that FGF8, FGF17 and FGF18 have already undergone some degree of
subfunctionalization in this territory and are not completely redundant.
Drosophila versus Tribolium—Recent analysis of the fully-sequenced genome of the
flour beetle, Tribolium castaneum, has revealed 4 FGF ligands (Tc-FGF1a, Tc-FGF1b, Tc-
FGF8, Tc-Bnl) and 1 FGF receptor (Tc-FGFR) are present (Beermann and Schröder, 2008).
Tribolium and Drosophila are >300 million years diverged, yet there is some conserved
microsynteny between FGF genes in the two species. The gene adjacent to pyramus
(CG13197, a predicted tyrosine phosphatase) is homologous to the gene upstream of Tc-
FGF8, Tc-00277.
There is only one member of the FGF8 subfamily in Tribolium, Tc-FGF8, but two in
Drosophila, thisbe and pyramus. The duplication to produce thisbe and pyramus is thought
to have occurred in the arthropod phylum before the radiation of insects because ths/pyr-like
sequences were found in one study to be represented in both dipterans and hymenopterans
(Popovici et al., 2005). However, the presence of only one FGF8 homolog in Tribolium
supports a different scenario where the duplication occurred in Dipterans. Alternatively, a
second FGF8-homolog may have been lost in the Tribolium genome. Genes similar to thisbe
and pyramus are present in all other Drosophila genomes sequenced so far (unpublished
observations), and further investigation of other insect genomes may allow us to point with
greater accuracy to the time in which this gene underwent duplication.
Ours and other labs are working on piecing together the overlapping and distinct functions
of pyramus and thisbe to understand how much functional redundancy remains and how far
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the process of subfunctionalization has gone in Drosophila. Both pyr and ths function during
gastrulation, specification of mesodermal subtypes, migration of caudal visceral mesoderm,
and in axonal migration and glial cell wrapping. In the axon there is a clear separation of
function for pyr and ths. Glial-derived pyr modulates glial cell numbers and motility
whereas neuronal-derived ths induces glial differentiation (Franzdóttir et al., 2009). Both
ligands were found to influence mesoderm spreading, whereas pyr is the dominant player
controlling Eve-positive cell specification in the dorsal mesoderm (Kadam et al., 2009;
Klingseisen et al., 2009). It therefore seems that the subfunctionalization of pyr and ths from
their insect FGF8-homolog ancestor is underway and pyr may either have some derived
functions or taken over functions once performed by the single gene.
Studies in Tribolium have shown the pyr/ths homolog, Tc-FGF8, is expressed in largely the
same domains as pyr/ths during embryogenesis, and so this gene is also likely involved in
spreading of the mesoderm, gut development and brain regionalization (Beermann and
Schröder, 2008). Tc-FGF8 is expressed in the developing brain during mid-segmentation. A
stripe of Tc-FGF8 expression in each head lobe divides the brain into a larger anterior and a
smaller posterior region, in a manner possibly analogous to the MHB in vertebrates. The
Drosophila embryonic brain is also divided into a tripartite pattern with an anterior
orthodenticle (otd) and posterior Hox domain and an intervening domain. pyr and ths,
however, are not expressed in this middle region, but are expressed in one neuroblast in the
anterior compartment in each hemibrain (Urbach 2007). Further functional characterization
of Tribolium FGFs will undoubtedly provide even more interesting comparisons to
Drosophila FGFs.
There are two members of the FGF1 subfamily in Tribolium, yet there is no member of the
FGF1 (A) subfamily in Drosophila. This indicates that Drosophila has lost the FGF1
subfamily. This is corroborated by the fact that the neighboring genes (sex-lethal interactor,
sin, and seven-in-absentia, sina) to FGF1a and FGF1b in Tribolium have conserved gene
order in Drosophila, but FGF1 is missing in Drosophila (Beermann and Schröder, 2008).
FGF1 is ubiquitously expressed and is known to play a developmental and maintenance role
of neuronal tissue (Beenken and Mohammadi, 2009). Possibly other genes in Drosophila
have taken over this function.
FGF variability and plasticity
FGFs are most conserved in the “core” FGF domain, however the conservation is often
weak, making phylogenetic analysis difficult. Other properties of FGF ligands including
secretion signals, homodimerization ability, glycosylation modifications, binding to HSPGs,
and other nonconserved domains in N- and C-terminal tails, can vary from molecule to
molecule. There is clearly a high level of plasticity in FGF signaling, the reason for which is
unknown but likely relates to the complex networks of regulation that these molecules are
involved in (Popovici et al., 2005). The 2nd and 3rd extracellular immunoglobulin (Ig)
domains of the FGF receptor are involved in binding the FGF ligands. The amino acid
sequence constraints imposed on Ig domains are less than for other protein domains, like
kinase domains (Popovici et al., 2005). The variability in the amino acid sequence of Ig
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domains relates to the high degree of variability in the amino acid composition of FGF
ligands (Popovici et al., 2005).
The FGF core domain is thought to be largely responsible for receptor binding. However,
the N- and C-terminal tails of FGF molecules are also thought to participate in FGF ligand-
receptor specificity. The N- and C-terminal tails can be of variable length. Drosophila FGF
have extraordinarily long C-terminal domains compared to the average FGF family member,
rendering them ~80kD in molecular weight compared to 18–30kD for the average FGF
ligand. Ciona also has a FGF with a large molecular mass, called Ci-FGFL. So far Ci-FGFL
has not been assigned to a particular FGF subfamily. Despite the evidence for the
importance of the sequence at the N- and C- termini, the function of nonconserved domains
outside the FGF domain has received little attention in most FGFs. Three notable exceptions
are the study of FGF9/FGF20 and FGF23 in vertebrates and LET-756 in C.elegans.
The crystal structures of both FGF9 and FGF20 were elucidated and, unlike other FGF
ligands, the N- and C-terminal regions were found to be ordered and involved in the
formation of a homodimer (two FGF9 ligands or two FGF20 ligands), which obscures the
receptor binding site (Kalinina et al., 2009; Plotnikov et al., 2001). The homodimerization
and ratio of dimers to monomers appears to autoregulate the ligands receptor binding ability
to diffuse through the ECM and bind to HSPGs (Harada et al., 2009; Kalinina et al., 2009).
FGF23 is part of a subgroup of endocrine FGFs. Full length FGF23 is 251 amino acids and
is cleaved in the C-terminal tail by subtilisin-like proprotein convertases between amino
acids 179 and 180. In humans, failure of this cleavage step results in secretion of additional
full-length FGF23, which can cause hypophosphatemia leading to autosomal dominant
hypophosphatemic rickets/osteomalacia (Benet-Pagès et al., 2004; Fukumoto, 2005).
The C-terminus of C. elegans LET-756 has been shown to contain several nuclear
localization signals and the function of them appears to be shuttling LET-756 between
several nuclear compartments (Popovici et al., 2006). Additionally, some nuclear
localization signals are redundant, highlighting the importance of nuclear localization for
LET-756, which has a viability function in C. elegans. Subnuclear localization is important
for function and LET-756 may be implicated in mRNA splicing machinery and ribosome
function (Popovici et al., 2006).
Recently, our lab has also undertaken the task of elucidating the function of the C-terminal
domains of Ths and Pyr [AS23]in Drosophila (Tulin and Stathopoulos, in review). We
found that despite their long length, these domains are not required for activity as truncated
constructs removing the C-terminus are functional in an overexpression assay. Additional
chimeric constructs revealed that the C-terminus of Ths, but not that of Pyr, may play a role
in the rate of ligand diffusion and/or potency. We also provide evidence that Ths and Pyr are
cleaved from their full-length forms into smaller FGFs in cell culture and these cleaved
forms are detectable in the embryo as well. In the embryo, cleaved forms of the FGF ligands
could be used to support long-range versus short-range functions as might be necessary
during the sequential steps of mesoderm migration, specifically in the control of mesoderm
tube collapse versus monolayer formation (McMahon et al., 2010).
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Use of the survey approach in FGFRL1
The ability to survey genomes from all major metazoan phyla is a powerful tool that allows
researchers to understand the degree of conservation of orthologous genes and to investigate
questions about whether similar mechanisms are being used. A good example of this
approach being used to study FGF signaling is seen in the study of FGFRL1 (fibroblast
growth factor like 1). FGFRL1, or FGFR5, is the most recently discovered member of the
FGFR family and has an ectodomain with high similarity to conventional FGFRs, but lacks
the catalytic tyrosine kinase domain in the intracellular domain (Sleeman et al., 2001;
Wiedemann and Trueb, 2000). FGFRL1 mutant mice die immediately after death with a
hypoplastic diaphram and also display skeletal alternations, craniofacial dysplasia, heart
valve defects, embryonic anemia, and defective kidney development (Baertschi et al., 2007;
Catela et al., 2009; Gerber et al., 2009). Initially it was thought that FGFRL1 was limited to
vertebrates, but Bertrand and colleagues have shown that there are orthologs in all metazoan
phyla and suggest it may represent a conserved regulatory mechanism for attenuating FGF
signaling (Bertrand et al., 2009). Some FGFRL1 orthologs have already been identified,
such as FGFRL1 in sea urchin, and others remain to be further investigated, like the putative
Drosophila ortholog CG31431 and the ortholog predicted in the cnidarian Nematostella.
Subsequent work on FGFRL1 in cell culture and Xenopus embryos has revealed that
increasing amounts of FGFR1 ectodomain is shed from primary myoblast cells when they
begin differentiating into myotubes (Steinberg et al., 2010). FGFRL1 was found to bind
several FGF ligands in both its membrane bound soluable state with high affinity. The
affinity of FGFRL1 for FGF3 is 1 order of magitude higher than the affinity of FGF3 for its
cognate receptor, FGFR2b, consistent with the model that FGFRL1 could act as a decoy
receptor to sequester ligand and attenuate signaling through FGFRs. Ectopic expression of
FGFRL1 in the Xenopus embryo resulted in a similar defect to that of the known phenotype
of a dominant-negative form of FGFR1, XFD, and could be rescued by injection of FGFR
mRNA.
The mechanism of FGF regulation by FGFRL1 type molecules appears to be widespread.
The platyhelminthes planarian Dugesua japonica, has a FGFRL molecule called nou-
darake, has been characterized as also having a similar phenotype as XFD in Xenopus
embryos (Cebrià et al., 2002).
There are still several unknowns with respect to FGFRL1, including the identity of the
protease responsible for shedding the ectodomain, the developmental processes and specific
FGF receptors it acts on during normal development, and the biological importance of a
polymorphism present in the human population affecting an amino acid involved in cleaving
FGFR1 (Steinberg et al., 2010). It will be exciting to see if similar mechanisms of FGF
regulation are present in phyla as far as Cnidaria and if work on orthologs in other models
can help answer the lingering questions as to the role of FGFRL1 in regulating FGF
signaling.
Conclusions and Outstanding Questions
In the context of the FGF superfamily, the mounting number of non-vertebrate FGFs is
adding to our knowledge of the evolution of FGF signaling and the variety of mechanisms
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available to these growth factors to regulate embryonic development. Important studies from
invertebrates have provided models of alternate splicing, subfunctionalization, regulation by
Sprouty proteins, and structural plasticity.
FGF signaling is important for human development and human health; therefore, research
will undoubtedly continue in all of the discussed areas and will likely provide targets for
medical applications. Importantly, FGF signaling is an ancient metazoan cell
communication mechanism predating the cnidarian – bilaterian divergence in the pre
Cambrian (>600 million years ago), and is utilized by all extant taxa surveyed to date‥
[DM27] This allows for a wealth of varied information that can be used in a number of ways
to complement the understanding of our own biology and answer questions about how
growth factor signaling has evolved and what mechanisms of signaling and regulation are
possible.
Some invertebrate FGF studies have provided very specific functional information. But
many studies in recently sequenced models are still based on inferences from expression
patterns or simply the presence of homologous domains in the genome. Much work remains
to be done to complete the details of the complex signaling and regulatory networks that are
present in FGF signaling to orchestrate the grand events of embryogenesis.
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Figure 1.
Simplified tree of Metazoa phyla containing species discussed in this review.
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Figure 2.
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